Procurement Summary
Country: USA
Summary: Dow Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award
Deadline: 30 Sep 2026
Posting Date: 05 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140656221
Document Ref. No.: HT942526ALSRPPCTA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
48814400 - Clinical information system
33141625 - Diagnostic kits
33698000 - Clinical products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Summary: The Fiscal Year 2026 (Fy26) Amyotrophic Lateral Sclerosis Research Program (Alsrp) Pilot Clinical Trial Award (Pcta) Supports The Rapid Implementation Of Clinical Trials With The Potential To Have A Significant Impact On The Treatment Or Management Of Amyotrophic Lateral Sclerosis (Als). Projects May Range From Phase 1 To Small-Scale Phase 2 Trials.Applications Must Address One Of The Following Focus Areas:· Biomarker-Driven Interventions: Disease-Modifying Interventions, With Mechanism-Specific Biomarkers To Predict Which Clinical Trial Participants Are Likely To Respond, Demonstrate Target Engagement, And Effects On The Intended Biological Pathway.· Clinical Care: Improving Aspects Of Clinical Care And Symptom Management For Als.Distinctive Features: Funding From This Award Mechanism Must Support A Clinical Trial. The Clinical Trial Should Begin No Later Than 12 Months After The Award Date Or 18 Months For U.S. Food And Drug Administration (Fda)-Regulated Studies.Projects Proposing A Therapeutic Intervention (Drug, Biologic, And/Or Device) Must Incorporate Biomarkers Specific To The Intervention Into The Trial Design.All Pre-Applications And Applications Are Required To Incorporate Community Collaboration, As Described In Section 3.2.2, To Optimize Research Impact.Applications Must Include A Detailed Regulatory Strategy Plan That Outlines The Approach For Obtaining Regulat...
Posted Date: 2026-05-04 00:00:00
Funding instrument type: Grant
Documents
Tender Notice